Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD

The phosphaturic hormone FGF23 is elevated in chronic kidney disease (CKD). The risk of premature death is substantially higher in the CKD patient population, with cardiovascular disease (CVD) as the leading mortality cause at all stages of CKD. Elevated FGF23 in CKD has been associated with increas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCI Insight
Asıl Yazarlar: Clinkenbeard, Erica L., Noonan, Megan L., Thomas, Joseph C., Ni, Pu, Hum, Julia M., Aref, Mohammad, Swallow, Elizabeth A., Moe, Sharon M., Allen, Matthew R., White, Kenneth E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478421/
https://ncbi.nlm.nih.gov/pubmed/30830862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.123817
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller